As a PGD inhibitor, 6-AN constricts the ability of tumor cells to utilize the PPP40 and may have additional on-target effects on glutathione (GSH) synthesis, via glutamine-cysteine ligase (GCLC)52. This evidence concerns the gene PGD and neoplasm.